Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 6 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Due to a rapid deterioration in the business environment for titanium dioxide for general-purpose applications, resulting from aggressive sales efforts by overseas competitors, particularly in China, and declining demand in the domestic market, the Company reviewed the recoverability of its fixed assets, recognized an impairment loss and recorded an extraordinary loss.
Impairment loss: ¥3,170 million
| Item | Details |
|---|---|
| Net Sales | ¥58,000 million → ¥57,373 million（-1.1%） |
| Operating profit | ¥1,700 million → ¥2,176 million（+28.0%） |
| Ordinary income | ¥2,100 million → ¥2,672 million（+27.2%） |
| Profit attributable to owners of the parent | ¥1,300 million → ¥-878 million |
| Net income per share | ¥56.09 → ¥-38.47 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 6 February 2026 |
| Previous-period results | Net sales: ¥55,737 million; operating profit: ¥3,525 million; ordinary profit: ¥3,747 million; net income attributable to owners of the parent: ¥2,422 million; earnings per share: ¥105.46 (fiscal year ended March 2025) |
| Reason for the revision | Due to a rapid deterioration in the business environment for titanium dioxide for general-purpose applications, resulting from aggressive sales efforts by overseas competitors, particularly in China, and declining demand in the domestic market, the Company reviewed the recoverability of its fixed assets, recognized an impairment loss and recorded an extraordinary loss. |
| Details and amount of extraordinary loss | Impairment loss: ¥3,170 million |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Due to a rapid deterioration in the business environment for titanium dioxide for general-purpose applications, resulting from aggressive sales efforts by overseas competitors, particularly in China, and declining demand in the domestic market, the Company recorded an impairment loss of ¥3,170 million as an extraordinary loss.